There are nearly 150,000 acute respiratory distress syndrome (ARDS) admissions in the USA, annually incurring 2.7 million hospital days. Although packed red blood cell (pRBC) transfusions increase ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

Faron Pharmaceuticals Ltd | Company announcement | April 17, 2025 at 15:15:00 EEST ...

TURKU, FI / ACCESS Newswire / April 17, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON)(HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on developing novel imm ...

has recommended the marketing authorization for vilobelimab as treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome who are receiving systemic corticosteroids as ...

In addition, MN-166 (ibudilast) was evaluated in patients that are at risk for developing acute respiratory distress syndrome (ARDS ... MN-166 (ibudilast), is currently in Phase 3 for amyotrophic ...

According to the U.S. Centers for Disease Control and Prevention (CDC), hantaviruses are a family of viruses that can cause severe, potentially fatal illnesses lncluding hantavirus pulmonary ...

The acute respiratory distress syndrome (ARDS) is an acute and severe form of microvascular ... ARDS is traditionally divided into three phases: exudative, proliferative and fibrotic (fig 1). The ...

InflaRx's Gohibic, a novel anti-C5a monoclonal antibody, has been authorized for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) who are also ...